Last reviewed · How we verify
NCT03599674: TNav
Targeted Inpatient Navigation to Improve Care for Minority Children and Families
NA trial testing Family Bridge Program in Hospitalized Children in 60 participants. Completed in 29 October 2018.
19 October 2018
Quick facts
| Lead sponsor | Seattle Children's Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 60 |
| Start date | 16 April 2018 |
| Primary completion | 19 October 2018 |
| Estimated completion | 29 October 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Family Bridge Program
Conditions studied
- Hospitalized Children — all drugs for Hospitalized Children →
Sponsor
Seattle Children's Hospital
Who can join
18 and older, any sex, with Hospitalized Children. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overall goal of this research is to evaluate a new program designed to address basic human needs, create a safe and supportive environment for families, and help families build skills and confidence for navigating the health care system. Specifically, we aim to pilot test the feasibility and acceptability of the Targeted Inpatient Navigation (TNav) program for families of low income, minority hospitalized children.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
A Realist Evaluation Analysis of a Novel Multi-Faceted Inpatient Patient Navigation Program.
Chisholm H, Kershaw T, Sotelo Guerra L, Bocek K, et al · · 2022 · cited 11× · PMID 34551342 · DOI 10.1016/j.acap.2021.09.009 -
Pilot Evaluation of the Family Bridge Program: A Communication- and Culture-Focused Inpatient Patient Navigation Program.
Lion KC, Arthur KC, Frías García M, Hsu C, et al · · 2024 · cited 10× · PMID 37354947 · DOI 10.1016/j.acap.2023.06.021
Verify or expand the search:
- PubMed search for NCT03599674
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Family Bridge Program
Trials testing the same drug.
- NCT06276621 — Family Bridge Program · NA · enrolling by invitation
Other recruiting trials for Hospitalized Children
Currently open trials in the same condition.
- NCT07038538 — Evidence-based Practice in the Management of Gastric Tube Placement in Children · NA · recruiting
- NCT06260345 — CommunautAry Pediatric bacteRial Infection in Intensive CarE Unit · recruiting
Other Seattle Children's Hospital trials
Trials by the same sponsor.
- NCT07522112 — Evaluating a Shared Decision-making Intervention for Families About Firearm Storage · NA · not yet recruiting
- NCT06864611 — Evaluating Huddles as a Novel Approach to Improving Concussion Safety · NA · not yet recruiting
- NCT07424157 — Long-Term Follow-Up of Subjects Treated With Seattle Children's Therapeutics Gene Therapy Products · not yet recruiting
- NCT07148050 — Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimer · Phase 1 · recruiting
- NCT07097792 — Concussion Recovery and Support Program · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03599674 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Seattle Children's Hospital
- Last refreshed: 25 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03599674.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing